Guy L. Odom

5.7k total citations · 1 hit paper
99 papers, 4.3k citations indexed

About

Guy L. Odom is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guy L. Odom has authored 99 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Neurology, 32 papers in Molecular Biology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guy L. Odom's work include Muscle Physiology and Disorders (23 papers), Intracranial Aneurysms: Treatment and Complications (16 papers) and Virus-based gene therapy research (15 papers). Guy L. Odom is often cited by papers focused on Muscle Physiology and Disorders (23 papers), Intracranial Aneurysms: Treatment and Complications (16 papers) and Virus-based gene therapy research (15 papers). Guy L. Odom collaborates with scholars based in United States, United Kingdom and Australia. Guy L. Odom's co-authors include Barnes Woodhall, Jeffrey S. Chamberlain, Robert H. Wilkins, M. S. Mahaley, George T. Tindall, John P. Kapp, Paul Gregorevic, George Margolis, John K. Hall and Kenneth R. Smith and has published in prestigious journals such as Nature Communications, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Guy L. Odom

96 papers receiving 3.7k citations

Hit Papers

align trajectories

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guy L. Odom United States	37	1.4k	1.3k	1.0k	682	592	99	4.3k
Gregory A. Helm United States	38	1.3k 0.9×	972 0.8×	875 0.9×	652 1.0×	353 0.6×	98	3.8k
John J. Kepes United States	37	1.6k 1.2×	847 0.7×	1.0k 1.0×	826 1.2×	497 0.8×	131	4.7k
Meena Upadhyaya United Kingdom	44	3.7k 2.6×	2.5k 1.9×	569 0.6×	1.4k 2.1×	830 1.4×	166	6.7k
Toshihiko Kubota Japan	31	853 0.6×	739 0.6×	677 0.7×	432 0.6×	322 0.5×	190	3.4k
H. Urich United Kingdom	31	1.1k 0.8×	719 0.6×	330 0.3×	440 0.6×	192 0.3×	104	3.0k
Renata Boldrini Italy	35	613 0.4×	1.5k 1.2×	904 0.9×	583 0.9×	187 0.3×	175	3.8k
M. Fukui Japan	31	1.6k 1.1×	715 0.6×	553 0.5×	635 0.9×	281 0.5×	140	3.7k
K. Roosen Germany	40	2.0k 1.4×	737 0.6×	677 0.7×	371 0.5×	280 0.5×	139	4.2k
Noriko Kimura Japan	29	647 0.5×	767 0.6×	2.0k 1.9×	506 0.7×	242 0.4×	188	4.6k
Kenneth M. Earle United States	30	1.3k 0.9×	515 0.4×	491 0.5×	751 1.1×	561 0.9×	57	3.5k

Countries citing papers authored by Guy L. Odom

Since Specialization

Citations

This map shows the geographic impact of Guy L. Odom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy L. Odom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy L. Odom more than expected).

Fields of papers citing papers by Guy L. Odom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy L. Odom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy L. Odom. The network helps show where Guy L. Odom may publish in the future.

Co-authorship network of co-authors of Guy L. Odom

This figure shows the co-authorship network connecting the top 25 collaborators of Guy L. Odom. A scholar is included among the top collaborators of Guy L. Odom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy L. Odom. Guy L. Odom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Dorn, Lisa E., Jeovanna Lowe, Neha Rastogi, et al.. (2021). Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model. JCI Insight. 6(7). 23 indexed citations

2.

Banks, Glen B., Jeffrey S. Chamberlain, & Guy L. Odom. (2020). Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects. PLoS Genetics. 16(11). e1009179–e1009179. 5 indexed citations

3.

Guiraud, Simon, Benjamin Edwards, Sarah Squire, et al.. (2018). Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice. Molecular Therapy — Methods & Clinical Development. 11. 92–105. 23 indexed citations

4.

Bengtsson, Niclas E., John K. Hall, Guy L. Odom, et al.. (2017). Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8(1). 14454–14454. 305 indexed citations

5.

Odom, Guy L., Charles E. Murry, Gregory G. Mahairas, et al.. (2016). Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy. JACC Basic to Translational Science. 1(7). 666–679. 10 indexed citations

6.

Kolwicz, Stephen C., Guy L. Odom, Farid Moussavi‐Harami, et al.. (2015). AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility. Molecular Therapy. 24(2). 240–250. 29 indexed citations

7.

Straková, Jana, et al.. (2014). Dystrobrevin increases dystrophin's binding to the dystrophin–glycoprotein complex and provides protection during cardiac stress. Journal of Molecular and Cellular Cardiology. 76. 106–115. 26 indexed citations

8.

Arnett, Andrea, Patryk Konieczny, Julian N. Ramos, et al.. (2014). Adeno-associated viral vectors do not efficiently target muscle satellite cells. Molecular Therapy — Methods & Clinical Development. 1. 14038–14038. 81 indexed citations

9.

Bieber, Scott D., Jeffrey B. Halldorson, Eric Finn, et al.. (2013). Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation. Scientific Reports. 3(1). 1538–1538. 2 indexed citations

10.

Seto, Jane T., Julian N. Ramos, Lindsey A. Muir, Jeffrey S. Chamberlain, & Guy L. Odom. (2012). Gene Replacement Therapies for Duchenne Muscular Dystrophy Using Adeno-Associated Viral Vectors. Current Gene Therapy. 12(3). 139–151. 23 indexed citations

11.

Korte, F. Steven, Guy L. Odom, Jin Dai, et al.. (2012). Broad Transgenic, and Cardiac-Specific Viral Mediated, Over-Expression of Ribonucleotide Reductase Increases In Vivo Cardiac Contractility. Biophysical Journal. 102(3). 615a–615a. 1 indexed citations

12.

Ng, Rainer, Glen B. Banks, John K. Hall, et al.. (2011). Animal Models of Muscular Dystrophy. Progress in molecular biology and translational science. 105. 83–111. 36 indexed citations

13.

Odom, Guy L., Glen B. Banks, Brian Schultz, Paul Gregorevic, & Jeffrey S. Chamberlain. (2010). Preclinical Studies for Gene Therapy of Duchenne Muscular Dystrophy. Journal of Child Neurology. 25(9). 1149–1157. 8 indexed citations

14.

Odom, Guy L., Paul Gregorevic, & Jeffrey S. Chamberlain. (2006). Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1772(2). 243–262. 79 indexed citations

15.

Roy‐Engel, Astrid M., et al.. (2005). Human retroelements may introduce intragenic polyadenylation signals. Cytogenetic and Genome Research. 110(1-4). 365–371. 62 indexed citations

16.

Odom, Guy L.. (2004). Predicting Mammalian SINE Subfamily Activity from A-tail Length. Molecular Biology and Evolution. 21(11). 2140–2148. 14 indexed citations

17.

Kolls, Jay K., et al.. (1997). Exacerbation of Murine Pneumocystis carinii Infection by Adenoviral-Mediated Gene Transfer of a TNF Inhibitor. American Journal of Respiratory Cell and Molecular Biology. 16(2). 112–118. 55 indexed citations

18.

Kolls, Jay K., Dinghua Lei, Guy L. Odom, et al.. (1996). Use of Transient CD4 Lymphocyte Depletion to Prolong Transgene Expression of E1-Deleted Adenoviral Vectors. Human Gene Therapy. 7(4). 489–497. 74 indexed citations

19.

Roberts, Dai, et al.. (1982). Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.. Molecular Pharmacology. 22(3). 760–765.

20.

Mahaley, M. S., Guy L. Odom, Barnes Woodhall, & Aaron P. Sanders. (1963). The use of externally monitored radioisotope techniques in the study of regional carotid blood flow under various experimental conditions. Journal of Surgical Research. 3(5). 227–236. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact